Becton Dickinson announced the commercial release of the BD Neopak XtraFlow Glass Prefillable Syringe and the latest capacity expansion of the BD Neopak Glass Prefillable Syringe platform to serve the growing market for biologic therapies.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- Merit Medical price target raised to $103 from $92 at BofA
- Edwards Lifesciences price target lowered to $71 from $82 at Truist
- Edwards Lifesciences price target lowered to $80 from $90 at Wells Fargo
- Election 2024: Where To Put Your Money Ahead of the Vote
- Becton Dickinson completes purchase of Critical Care from Edwards Lifesciences